Sai Life Sciences, the Telangana-based pharma company, is not having the best time at the equity markets as the company's downward slide in stock price continues.
Sai Life Shares Continue To Trade In Red
On Monday, January 27, the value of the company shares slipped further after a week of decline over multiple trading sessions.
As per latest numbers, the company shares that were listed only in December 2024 declined by a mammoth 8.16 per cent in just a month.
Expansion Plans On Cards
This comes despite expansion plans chartered by the company. The company announced in an exchange filing that the was looking to expand its Research & Development (R&D) capabilities.
The company announced in an exchange filing that it was looking to expand its Research & Development (R&D) capabilities.
This piece of land with other structures is located in Shamirpet, Hyderabad. This land deal incurred the company Rs 15 crore. In addition, . This property will be used to build an R&D facility in order to complement the existing Unit II Hyderabad facility.
Sai Life Sciences Ltd
As we take a look at the performance of the company at Dalal Street, we see the shares continue to trade with cuts. As of Monday, while approaching the halfway mark, the company shares declined by over 2 per cent or in excess of Rs 14.
This came to pass after some vacillation in the value. The shares opened for the day at Rs 673.90, marginally higher than the previous day's settlement of Rs 674.35 per share.
A look at the larger picture, shows an even bigger trend of decline for the company, that was listed at exchanges on December 18.
In the past five trading sessions, the company shares declined by even bigger margin. The week-long decline stood at a colossal 11 per cent or in excess of Rs 80 per share. This has brought the overall of stock to Rs 660.40 per share.
